Pancreatic Cancer Metabolism: Molecular Mechanisms and Clinical Applications

Pancreatic Cancer Metabolism: Molecular Mechanisms and Clinical Applications Purpose of Review Pancreatic adenocarcinoma is a leading cause of cancer mortality in western countries with a uniformly poor prognosis. Unfortunately, there has been little in the way of novel therapeutics for this malignancy over the last several decades. Derangements in metabolic circuitry favoring excess glycolysis are increasingly recognized as a key hallmark of cancer. Recent Findings The role of alterations in glutamine metabolism in pancreatic tumor progression has been elucidated in animal models and human cells lines, and there has been considerable interest in exploiting these aberrations for the treatment of pancreatic cancer. Other strategies targeting NQO1/GLS1 inhibition, NAD+ synthesis, and TCA cycle intermediates are being actively studied in the clinic. Summary Aberrant metabolism in pancreatic cancer poses a unique therapeutic strategy. We review preclinical and clinical studies looking to exploit alterations in the metabolic circuitry of pancreatic cancer. . . . . Keywords Pancreatic cancer Glutamine Anaplerosis NADPH-quinone oxidoreductase 1 ß-lapachone Abbreviations ROS Reactive oxygen species α-KG α-Ketoglutarate TCA Tricarboxylic acid cycle β-lap β-Lapchone BPTES Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2- yl)ethyl sulfide Introduction Gln Glutamine GlnI Glutamine synthase Pancreatic adenocarcinoma (PDAC) is a leading cause of Gls1 Glutaminase 1 cancer-related mortality in western countries. In the USA, Gls2 Glutaminase 2 there http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Oncology Reports Springer Journals

Pancreatic Cancer Metabolism: Molecular Mechanisms and Clinical Applications

Loading next page...
 
/lp/springer_journal/pancreatic-cancer-metabolism-molecular-mechanisms-and-clinical-0AQf80S2gs
Publisher
Springer US
Copyright
Copyright © 2018 by Springer Science+Business Media, LLC, part of Springer Nature
Subject
Medicine & Public Health; Oncology
ISSN
1523-3790
eISSN
1534-6269
D.O.I.
10.1007/s11912-018-0699-5
Publisher site
See Article on Publisher Site

Abstract

Purpose of Review Pancreatic adenocarcinoma is a leading cause of cancer mortality in western countries with a uniformly poor prognosis. Unfortunately, there has been little in the way of novel therapeutics for this malignancy over the last several decades. Derangements in metabolic circuitry favoring excess glycolysis are increasingly recognized as a key hallmark of cancer. Recent Findings The role of alterations in glutamine metabolism in pancreatic tumor progression has been elucidated in animal models and human cells lines, and there has been considerable interest in exploiting these aberrations for the treatment of pancreatic cancer. Other strategies targeting NQO1/GLS1 inhibition, NAD+ synthesis, and TCA cycle intermediates are being actively studied in the clinic. Summary Aberrant metabolism in pancreatic cancer poses a unique therapeutic strategy. We review preclinical and clinical studies looking to exploit alterations in the metabolic circuitry of pancreatic cancer. . . . . Keywords Pancreatic cancer Glutamine Anaplerosis NADPH-quinone oxidoreductase 1 ß-lapachone Abbreviations ROS Reactive oxygen species α-KG α-Ketoglutarate TCA Tricarboxylic acid cycle β-lap β-Lapchone BPTES Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2- yl)ethyl sulfide Introduction Gln Glutamine GlnI Glutamine synthase Pancreatic adenocarcinoma (PDAC) is a leading cause of Gls1 Glutaminase 1 cancer-related mortality in western countries. In the USA, Gls2 Glutaminase 2 there

Journal

Current Oncology ReportsSpringer Journals

Published: May 11, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off